KANK1 Gene Cerebral Palsy Type 2 Spastic Quadriplegic Genetic Test
At DNA Labs UAE, we offer the KANK1 Gene Cerebral Palsy Type 2 Spastic Quadriplegic Genetic Test. This test is designed to analyze the DNA sequence of the KANK1 gene and identify any variations or mutations that may be contributing to the development of cerebral palsy type 2, spastic quadriplegic.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 164 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the KANK1 Gene Cerebral Palsy Type 2 Spastic Quadriplegic Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with KANK1 Gene Cerebral Palsy Type 2, spastic quadriplegic.
Test Details
The KANK1 gene is associated with cerebral palsy type 2, spastic quadriplegic. Through NGS genetic testing, we can analyze the DNA sequence of the KANK1 gene and identify any variations or mutations. This information can help provide a more accurate diagnosis, predict the likelihood of the condition being passed on to future generations, and inform treatment options.
Test Name | KANK1 Gene Cerebral palsy type 2 spastic quadriplegic Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 164 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KANK1 Gene Cerebral palsy type 2, spastic quadriplegic NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KANK1 Gene Cerebral palsy type 2, spastic quadriplegic |
Test Details |
The KANK1 gene is associated with cerebral palsy type 2, spastic quadriplegic. NGS genetic testing can be used to analyze the DNA sequence of the KANK1 gene and identify any variations or mutations that may be contributing to the development of this condition. This information can be used to provide a more accurate diagnosis, predict the likelihood of the condition being passed on to future generations, and inform treatment options. |